COMPANIES COVERED
GlaxoSmithKline plc.Download FREE Report Sample
Download Free sampleRestless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads to the unusual sleep pattern of patients.
Restless Legs Syndrome Market contains market size and forecasts of Restless Legs Syndrome in Global, including the following market information:
Global Restless Legs Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Restless Legs Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pharmacological Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Restless Legs Syndrome include GlaxoSmithKline plc., Ligand Pharmaceuticals Incorporated, axxonis Pharma AG, Kyowa Hakko Kirin, Jazz Pharmaceuticals, Omeros Corporation, Manhattan Pharmaceuticals, Boehringer Ingelheim GmbH and UCB SA. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Wesurveyed the Restless Legs Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Restless Legs Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Restless Legs Syndrome Market Segment Percentages, by Type, 2021 (%)
Pharmacological Therapy
Non-Pharmacological Therapy
Global Restless Legs Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Restless Legs Syndrome Market Segment Percentages, by Application, 2021 (%)
Below 35 YearsOld
35-50 Years Old
Above50 YearsOld
Global Restless Legs Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Restless Legs Syndrome Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Restless Legs Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Restless Legs Syndrome revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline plc.
Ligand Pharmaceuticals Incorporated
axxonis Pharma AG
Kyowa Hakko Kirin
Jazz Pharmaceuticals
Omeros Corporation
Manhattan Pharmaceuticals
Boehringer Ingelheim GmbH
UCB SA
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
